Related Experiment Video
Updated: May 16, 2025
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination:
Joanna J Regan1, Zanju Wang1, Christina R Phares1
1Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background:
It is not recommended to perform tuberculin skin tests (TSTs) or interferon-γ release assays (IGRAs) in the 4 weeks following live-virus vaccination because these vaccines are thought to increase the risk of false-negative results.
Methods:
We retrospectively analyzed TST and IGRA results for 158 484 US-bound immigrant and refugee children aged 2-14 years who received a required medical examination and live-virus vaccines (measles, mumps, rubella; oral polio; or varicella) overseas during 2014-2022. We created logistic regression models to assess the association between test positivity and vaccination during the critical interval (1-28 days after live-virus vaccination) versus after or before, adjusting for sex, age group, country of examination, and other factors.
Results:
The percentage of positive results and the adjusted odds of a positive IGRA result were higher for children tested during the critical interval (4.6%) than for those tested after (3.5%) (adjusted odds ratio, 1.27 [95% confidence interval, 1.13-1.43) or before (3.3%) (1.26 [1.13-1.41]). The percentage of positive results and the adjusted odds of a positive TST were also higher for children tested during the critical interval (15.7%) than for those tested after (7.2%) (adjusted odds ratio, 2.40 [95% confidence interval, 1.79-3.22]) or before (6.6%) (3.81 [2.80--5.18]).
Conclusions:
The concern that recent administration of live-virus vaccines leads to false-negative TST and IGRA results is not supported by these findings. Instead, we observed a modest increase in positive results among children tested during the critical postvaccination interval, challenging the need for the testing delay.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
08:10A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:51Vaccinations